Patents Assigned to SHUJING BIOPHARMA CO., LTD
  • Publication number: 20240368115
    Abstract: The present application relates to a regulator containing a tricyclic derivative, a preparation method therefor and an application thereof, and in particular to a compound represented by general formula (Ia), a preparation method therefor and a pharmaceutical composition containing the compound, and an application thereof in the preparation of drugs for preventing and/or treating central nervous system diseases and/or peripheral diseases related to mammalian 5-hydroxytryptamine and/or dopamine and/or norepinephrine neurotransmitter transmission.
    Type: Application
    Filed: August 4, 2022
    Publication date: November 7, 2024
    Applicants: SHUJING BIOPHARMA CO., LTD, JIANGSU NHWA PHARMACEUTICAL CO., LTD
    Inventors: Jun QIN, Yangyang WENG, Jin CAI, Zehong WAN
  • Publication number: 20240336583
    Abstract: The present invention relates to a benzo-ring-containing derivative, and a preparation method therefor and the use thereof. Specifically, the present invention relates to a compound as represented by general formula (Ia), and a preparation method therefor, a pharmaceutical composition containing same, and the use thereof as a GABA receptor agonist in the field of the central nervous system, specifically in inducing and maintaining anesthesia of mammals.
    Type: Application
    Filed: August 5, 2022
    Publication date: October 10, 2024
    Applicants: SHUJING BIOPHARMA CO., LTD, JIANGSU NHWA PHARMACEUTICAL CO., LTD
    Inventors: Jiaquan FENG, Yuanhai ZOU, Zehong WAN
  • Publication number: 20240190888
    Abstract: Provided are a spiro-containing derivative, and a preparation method therefor and the use thereof. In particular, provided are a compound as shown in general formula (I), and a preparation method therefor, a pharmaceutical composition containing same, and the use thereof in the preparation of a drug for preventing and/or treating central nervous system diseases related to 5-hydroxytryptamine receptors and/or trace amine-related receptors and/or dopamine receptors in mammals.
    Type: Application
    Filed: March 28, 2022
    Publication date: June 13, 2024
    Applicants: SHUJING BIOPHARMA CO., LTD, JIANGSU NHWA PHARMACEUTICAL CO., LTD
    Inventors: Jun QIN, Yongqi WU, Jiaquan FENG, Wei HUANG, Yuanhai ZOU, Bingcheng ZHOU, Zhijing HU, Xinjian JIANG, Zehong WAN